Author:
Munsell Mary K.,Fadelu Temidayo,Stuver Sherri O.,Baker Katherine P.,Glotzbecker Brett,Simmons Justin L.,Reynolds Kerry L.,Patel Ami K.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference40 articles.
1. Abbasi A, Corpeleijn E, Postmus D, Gansevoort RT, De Jong PE, Gans ROB, Struck J et al (2010) Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome. J Clin Endocr Metab 95(9):E26-31. https://doi.org/10.1210/jc.2010-0305
2. Avrillon V, Locatelli-Sanchez M, Folliet L, Carbonnaux M, Perino E, Fossard G, Desseigne M et al (2015) Lung cancer may increase serum procalcitonin level. Infect Disord Drug Targets 15(1):57–63. https://doi.org/10.2174/1871526515666150320162950
3. Aziz SA, Nelwan EJ, Sukrisman L, Suhendro S (2018) Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients. BMC Res Notes 11:84. https://doi.org/10.1186/s13104-018-3204-1
4. Bansal A, Jeyaraman P, Gupta SK, Dayal N, Naithani R (2020) Clinical utility of procalcitonin in bacterial infections in patients undergoing hematopoietic stem cell transplantation. Am J Blood Res 10(6):339–344
5. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG et al (2015) STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies. Brit Med J 351:h5527
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献